Honey Blankenship/LinkedIn
Aug 16, 2026, 13:53
Honey Blankenship: United by a Shared Commitment to the Bleeding Disorders Community
Honey Blankenship, Hemophilia Patient Navigator at Pfizer, shared on LinkedIn:
”Coming home from an incredible conference feeling especially grateful.
Grateful for the patients, healthcare providers, advocacy groups, and industry partners who came together with a shared commitment to making a difference for the bleeding disorders community.
Most of all, I’m grateful for the relationships and lifelong friendships that continue to grow through this work.
I feel incredibly fortunate to work for a company that gives me the opportunity to support patients and contribute to a community that inspires me every day.
Leaving with a full heart, new connections, and even more motivation for the work ahead.”
Stay updated with Hemostasis Today.
-
Oct 12, 2026, 17:53Donna Morelli: Hydroxyurea Safe and Effective for Pediatric Sickle Cell in Africa
-
Oct 12, 2026, 17:39Annie Bauzon: Differentiating Direct and Indirect Coombs Tests in Hematology
-
Oct 12, 2026, 17:15Cedric Hermans: Identifying and Diagnosing Hemophilia Carriers and Affected Females
-
Oct 12, 2026, 17:01Bianca Rocca: Evaluating Factor XI Inhibition Lessons from LIBREXIA-ACS
-
Oct 12, 2026, 13:58Francisco Chacón-Lozsán: Catastrophic Antiphospholipid Syndrome A Rapidly Progressive Multiorgan Thrombotic Emergency
-
Oct 12, 2026, 12:50Nawsherwan Mohammad: Study Examines Thrombotic Events in Patients with Polycythemia Vera in Iraq
-
Oct 12, 2026, 12:30Chanakya Nayudu: Looking Beyond Blood Clots – Patient-Reported Outcomes in Antiphospholipid Syndrome
-
Oct 12, 2026, 12:12Jean-Jacques Kiladjian: Improving Treatment Strategies with JAK Inhibitors in Myelofibrosis
-
Oct 12, 2026, 12:04Chloe Homich: AABB Annual Meetings – Building Connections and Advancing Transfusion Medicine